title: Clinical and mutational profile in spinal muscular atrophy with respiratory distress (SMARD): defining novel phenotypes through hierarchical cluster analysis.
abstract: Autosomal recessive spinal muscular atrophy with respiratory distress (SMARD) is a heterogeneous disorder. Mutations in the immunoglobulin micro-binding protein gene (IGHMBP2) lead to SMARD1, but clinical criteria that delineate SMARD1 from other SMARD syndromes are not well established. Here we present a retrospective clinical and genetic study to determine the criteria that would predict the presence or absence of IGHMBP2 mutations. From 141 patients with respiratory distress and a spinal muscular atrophy phenotype we recorded the clinical features through a questionnaire and sequenced the entire coding region of IGHMBP2. In 47 (33%) patients we identified IGHMBP2 mutations, 14 of which were not described before. Clinical features and combinations thereof associated with the presence of IGHMBP2 mutations were discovered through hierarchical cluster analysis. This method detects common traits not evident at first sight by grouping items according to their similarity. The combination of "manifestation of respiratory failure between 6 weeks and 6 months" AND ("presence of diaphragmatic eventration" OR "preterm birth") predicted the presence of IGHMBP2 mutations with 98% sensitivity and 92% specificity. Non-SMARD1 patients fell into two different symptom clusters, mainly separated by the age at respiratory failure and the presence of multiple congenital contractures. The 14 novel IGHMBP2 mutations comprised missense, frameshift, splice-site, and nonsense mutations. All missense mutations altered conserved residues within or adjacent to the putative DNA helicase domain. The c.1235+3A>G splice-site mutation did not entirely suppress correct splicing and we found a residual wild-type IGHMBP2 mRNA steady-state level of 24.4+/-6.9%, which was, however, not sufficient to avert SMARD1 in this patient.
authors: Department of Biology, Chemistry, and Pharmacy, Free University of Berlin, Germany.
authors: Ulf-Peter
authors: UP
authors: Guenther
authors: Raymonda
authors: R
authors: Varon
authors: Maria
authors: M
authors: Schlicke
authors: Véronique
authors: V
authors: Dutrannoy
authors: Alexander
authors: A
authors: Volk
authors: Christoph
authors: C
authors: Hübner
authors: Katja
authors: K
authors: von Au
authors: Markus
authors: M
authors: Schuelke
mesh_terms: D016009:Chi-Square Distribution; D016000:Cluster Analysis; D015331:Cohort Studies; D004252:DNA Mutational Analysis; D018076:DNA, Complementary; D004268:DNA-Binding Proteins / Q000235:genetics; D005786:Gene Expression Regulation; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D009134:Muscular Atrophy, Spinal / Q000150:complications* / Q000235:genetics* / Q000473:pathology; D009154:Mutation / Q000235:genetics*; D010641:Phenotype; D012120:Respiration Disorders / Q000150:complications* / Q000235:genetics* / Q000473:pathology; D014157:Transcription Factors / Q000235:genetics
chemical_list: D018076:DNA, Complementary; D004268:DNA-Binding Proteins; C489892:IGHMBP2 protein, human; D014157:Transcription Factors